Evidence map›Paper›PMID 35212702›Full record

ArticleJornal brasileiro de nefrologia

Brazilian Dialysis Survey 2020.

Fabiana B Nerbass, Helbert do Nascimento Lima, Fernando Saldanha Thomé, Osvaldo Merege Vieira Neto, Jocemir Ronaldo Lugon, Ricardo Sesso

Open access · diamondAbstract read
In one paragraph

Article in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Observational
  18. Brazilian Dialysis Survey 2021.Jornal brasileiro de nefrologia
    Article
  19. Urgent-start peritoneal dialysis.Jornal brasileiro de nefrologia
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Fabiana B NerbassFundação Pró-Rim, Joinville, SC, Brasil.ORCID http://orcid.org/0000-0001-9936-0185
Helbert do Nascimento LimaUniversidade da Região de Joinville, Joinville, SC, Brasil.ORCID http://orcid.org/0000-0003-0081-6897
Fernando Saldanha ThoméUniversidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.ORCID http://orcid.org/0000-0001-5378-3510
Osvaldo Merege Vieira NetoUniversidade de São Paulo, Ribeirão Preto, SP, Brasil.
Jocemir Ronaldo LugonUniversidade Federal Fluminense, Niterói, RJ, Brasil.ORCID http://orcid.org/0000-0001-6791-3910
Ricardo SessoUniversidade Federal de São Paulo, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-1062-0073
Hospital do Rim e Hipertensão · BRUniversidade da Região de Joinville · BRUniversidade de São Paulo · BRUniversidade Federal de São Paulo · BRUniversidade Federal do Rio Grande do Sul · BRUniversidade Federal Fluminense · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNational data on chronic dialysis treatment are essential to support the development of health policies aimed at improving the treatment for thousands of people.

objectiveTo report epidemiological data from the 2020 Brazilian Dialysis Survey, sponsored by the Brazilian Society of Nephrology.

methodsA survey was carried out in Brazilian chronic dialysis centers using an online questionnaire for the year, covering clinical and epidemiological aspects of patients in a chronic dialysis program, data on dialysis therapy, characteristics of dialysis units and the impact of the COVID-19 pandemic.

results235 (28%) of the centers responded to the questionnaire. In July 2020, the estimated total number of patients on dialysis was 144,779. The estimated prevalence and incidence rates of patients per million population (pmp) were 684 and 209, respectively. Of the prevalent patients, 92.6% were on hemodialysis (HD) and 7.4% were on peritoneal dialysis (PD); 23% were on the transplant waiting list. A central venous catheter was used by a quarter of patients on HD. The incidence rate of confirmed COVID-19 between February and July 2020 was 684/10,000 dialysis patients, and the lethality rate was 25.7%. The estimated overall mortality and COVID-19 crude annual mortality rates were 24.5 and 4.2%, respectively.

conclusionThe absolute number of patients on chronic dialysis and prevalence rate continued to increase. The low use of PD as dialysis therapy was maintained and the use of long-term catheters for HD increased. The COVID-19 pandemic contributed to the increase in the overall mortality rate.

Indexed as

COVID-19Kidney Failure, ChronicBrazilHumansPandemicsRenal DialysisSurveys and Questionnaires

Identifiers

PMID35212702
PMCPMC9518621
OpenAlexW4212824868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.